- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01174329
Treatment of Salivary Gland Hypofunction With Neuro- Electrostimulation (SALELECTROSTIM)
August 17, 2010 updated by: Universidad Autonoma de Nuevo Leon
Difference in Salivary Flow in Patients With Salivary Gland Hypofunction of the Following Application of Neuro-electrostimulation
The objective of the study is to evaluate with clinical parameters the performance of Saliwell Crown as a neuro-electrostimulator of the submandibular and sublingual salivary glands in hypofunction status due to polypharmacy or Sjögren's Syndrome in patients with symptoms of xerostomia.
Study Overview
Status
Unknown
Conditions
Study Type
Interventional
Enrollment (Anticipated)
14
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nuevo León
-
Monterrey, Nuevo León, Mexico
- Recruiting
- C.D. Especialidad de Periodoncia
-
Contact:
- María G Chapa Arizpe, Dr.
- Phone Number: +52 81 83 46 62 62
- Email: maiech@hotmail.com
-
Contact:
- Phone Number: +52 81 83 29 42 50
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age range between 18 and 75 years of age
- Clinical symptoms of xerostomia
- Difference in whole salivary flow between resting and stimulating conditions
- Patient ASA type I to III
- Absence of at least one mandibular third molar inferior, but at least partially dentated in the mandible
Exclusion Criteria:
- Patients with antimicrobial treatments in the three previous months
- Smokers
- Intake of bisphosphonates
- Limitation of mandibular opening
- Interoclusal distance smaller than 10 millimetres
- Lack of adequate bone availability for implant placement
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Patient-regulated neuro-electrostimulation by "Saliwell Crown"
Patient regulated (by a remote control) neuro-electrostimulation by "Saliwell Crown"
|
On-demand stimulation of the lingual nerveby "Saliwell Crown"
|
|
Active Comparator: Automatic neuro-electrostimulation by "Saliwell Crown"
No remote control used
|
Continuous stimulation of the lingual nerve by "Saliwell Crown"
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
self-reported xerostomia
Time Frame: 4 weeks
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2010
Primary Completion (Anticipated)
December 1, 2010
Study Registration Dates
First Submitted
July 28, 2010
First Submitted That Met QC Criteria
August 2, 2010
First Posted (Estimate)
August 3, 2010
Study Record Updates
Last Update Posted (Estimate)
August 18, 2010
Last Update Submitted That Met QC Criteria
August 17, 2010
Last Verified
July 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Immune System Diseases
- Autoimmune Diseases
- Eye Diseases
- Joint Diseases
- Musculoskeletal Diseases
- Rheumatic Diseases
- Connective Tissue Diseases
- Arthritis
- Stomatognathic Diseases
- Mouth Diseases
- Lacrimal Apparatus Diseases
- Arthritis, Rheumatoid
- Salivary Gland Diseases
- Dry Eye Syndromes
- Sjogren's Syndrome
- Xerostomia
Other Study ID Numbers
- 1234 (Department of Defense)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Xerostomia
-
University of BrasiliaNot yet recruitingXerostomia Following Radiotherapy
-
Poznan University of Medical SciencesEnrolling by invitationXerostomia Due to Hyposecretion of Salivary GlandPoland
-
Bedford Hospital NHS TrustUnknownXerostomia | Xerostomia Due to Radiotherapy | Xerostomia Due to Hyposecretion of Salivary Gland
-
MeiraGTx, LLCActive, not recruitingRadiation-induced XerostomiaUnited States, Canada
-
Thomas KuhntVerband Deutscher DruckkammerzentrenTerminatedRadiation-induced XerostomiaGermany
-
Laboratoires CARILENEDERMSCAN-PHARMASCAN GROUP in charge of data analysisCompleted
-
Institute of Oncology LjubljanaUniversity Medical Centre Ljubljana; University of Ljubljana; Blood Transfusion...Not yet recruitingXerostomia Following RadiotherapySlovenia
-
Catholic University of the Sacred HeartSunstar Italiana SRL.CompletedXerostomia | Xerostomia Following RadiotherapyItaly
-
Qazvin University Of Medical SciencesImam Khomeini HospitalCompletedRadiation-Induced XerostomiaIran, Islamic Republic of